Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
整合基线ctDNA衍生肿瘤指标可增强HR阳性/HER2阴性晚期乳腺癌的风险分层：一项来自奥地利的真实世界多中心队列研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106939
Dobrić, N; Hasenleithner, S O; Suppan, C; Klocker, E V; Hlauschek, D; Graf, R; Beichler, C; Albertini, C; Egle, D; Liu, D; Starzer, A M; Bartsch, R; Moser, T; Rinnerthaler, G; Jost, P J; Heitzer, E; Dandachi, N; Balic, M
